NovaBay
Pharmaceuticals, Inc. (NYSE:NBY) announces that the New York Stock Exchange
(NYSE) has accepted the Company’s plan to regain compliance with the NYSE
American’s continued listing standards. As previously disclosed, the NYSE
notified the Company on April 12, 2019 and May 16, 2019 that it was out of
compliance with Exchange listing requirements.
The insider ownership percentage is the key indicator,
can be used by investors, to measure the outlook of senior management has on
their company. Insider ownership for the NBY is 55.20%. Institutional ownership
refers to the ownership stake in a company that is held by large financial
organizations, pension funds or endowments. The Institutional ownership for the
NBY is 1.10%.
Insider trading is the buying or selling of any publicly traded company’s stock
and this can be done by someone who has non-public, material information about
that NBY. Insider trading can be illegal or legal depending on when the insider
makes the trade. It is illegal when the material information is still non-public.
The insider transactions of the company (6-month change in insider ownerships)
for the NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is -4.04%.
Institutional ownership is the amount of a NovaBay Pharmaceuticals, Inc.
(NYSE:NBY)’s available stock owned by mutual or pension funds, insurance
companies, investment firms, private foundations, endowments or other large
entities that actually manage the funds on the behalf of others, so its an
interesting element for the traders to note it, and the Institutional ownership
for the NBY is 22.26%.
U.S traded NovaBay Pharmaceuticals, Inc. (NYSE:NBY) stock slumped -2.31% on
Friday and when day-trade ended the stock finally concluded at $1.69 and number
of shares that changed hands during the day are 321038. The number of shares
NBY stock currently held by all its shareholders are 19.47 and floated shares,
the number of shares are available for trading in an open market on last
trading day are 7.46. The average volume of shares for 3 months is 2543.87 and
NBY stock value has moved between $0.23 – 4.02 in last one year.
The NovaBay Pharmaceuticals, Inc. (NYSE:NBY) reported its last earnings on date
8/8/2019. The Gross margin is the difference between the revenue and the cost
of goods sold (COGS), divided by revenue. In other words, Gross Margin is a
percentage value, while Gross Profit is a monetary value. The valuable gross
margin for NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is 85.60% and the profit
margin is -77.70% and the stock has gained 118.71% in 2019 to date.
U.S. traded shares of NovaBay Pharmaceuticals, Inc. (NYSE:NBY)’s monthly stock
performance is 461.46%, the quarterly performance is 40.83%, the half year
performance is calculated as 96.51%. The yearly performance of NBY is -30.30%.
The higher the volatility, the riskier the security. For example, when the
stock market rises and falls more than one percent over a sustained period of
time, it is called a “volatile” market, if the stock price stays
relatively stable, the security has low volatility. The NovaBay
Pharmaceuticals, Inc. (NYSE:NBY) weekly volatility is measured as 8.02% and
monthly volatility measured as 37.99%.
Return on assets (ROA) is a main indicator of how profitable a company is
relative to its total assets. NBY return on assets is -83.40%, the return on
equity (ROE) of the NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is -175.40%, while
the most important return on investment is calculates as a percentage and is
typically used for personal financial decisions, and NBY return on investment
is -157.50%.
The price to sales ratio is 2.96, and price to book ratio is 24.14, price to
cash per share ration is 11.35.
Analysts mean target price for NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is
$1.25 while analysts mean recommendation is 2.50. The current share price
indicates that stock is -58.17% away from its one year high and is moving
637.99% ahead of its 52-week low. NBY’s distance from 20 day simple moving
average is 13.78% and distance from 50-Day simple moving average is 68.08%.
